← Back to Search

Exercise for Kidney Failure

N/A
Recruiting
Led By Deborah Zimmerman, MD, MSc
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ambulatory adult patients with end stage kidney disease
Treatment with peritoneal dialysis or hemodialysis for greater than six months
Must not have
Planned living donor kidney transplant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if an exercise intervention can help improve patient outcomes vs. the standard of care over a 3 year period.

Who is the study for?
This trial is for adults with end stage kidney disease who have been on dialysis for over six months, can walk, understand English or French, and are willing to use Nordic Walking poles. It's not suitable for those with conditions like unstable angina or uncontrolled high blood pressure, a daily step count over 8000 steps, an upcoming kidney transplant from a living donor, potential renal recovery, reliance on other mobility aids they feel unsafe replacing with walking poles, or participation in another conflicting trial.
What is being tested?
The study tests if exercise helps people receiving chronic dialysis. Participants will be randomly assigned to either receive standard care or add an exercise program using Nordic Walking poles and online resources for one year. Their progress will be tracked with pedometers and encouraged by staff monthly.
What are the potential side effects?
Since the intervention involves physical activity through prescribed exercises including Nordic Walking pole usage and monitoring via pedometer, side effects may include typical exercise-related issues such as muscle soreness or strain but should generally be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have severe kidney disease and can walk.
Select...
I have been on dialysis for more than 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am scheduled for a kidney transplant from a living donor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence
Recruitment Feasibility
Secondary study objectives
Change in Living Status
Hand Grip Strength
Hospital Length of Stay
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise InterventionExperimental Treatment1 Intervention
Participants in this arm will receive standard of care along with the exercise prescription intervention
Group II: Standard of CareActive Control1 Intervention
This group will receive standard of care treatment including regular verbal encouragement to exercise (monthly) by dialysis unit staff.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Prescription
2009
N/A
~180

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
575 Previous Clinical Trials
3,094,810 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,389 Previous Clinical Trials
26,519,354 Total Patients Enrolled
2 Trials studying Kidney Failure
398 Patients Enrolled for Kidney Failure
Deborah Zimmerman, MD, MScPrincipal InvestigatorOttawa Hospital Research Institute
2 Previous Clinical Trials
26 Total Patients Enrolled

Media Library

Exercise Prescription Clinical Trial Eligibility Overview. Trial Name: NCT03787589 — N/A
Kidney Failure Research Study Groups: Exercise Intervention, Standard of Care
Kidney Failure Clinical Trial 2023: Exercise Prescription Highlights & Side Effects. Trial Name: NCT03787589 — N/A
Exercise Prescription 2023 Treatment Timeline for Medical Study. Trial Name: NCT03787589 — N/A
~3 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top